[125I]Tyr-Ala-hexarelin [7785]
[125I]Tyr-Ala-hexarelin
| SMILES |
C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O |
| InChIKey |
ODZXFAKPKDUICF-GCUJDKQKSA-N |
| Sequence |
YAHWAWFK |
| HELM |
PEPTIDE1{Y.A.H.W.A.W.F.K}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
12 |
| Hydrogen bond donors |
14 |
| Rotatable bonds |
29 |
| Log P |
1.566 |
| Molecular weight (Da) |
1107.5 |
| Stereochemistry info |
unspecified |
| Radioactive |
125I |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.